Yu NX, Yang LM, Lu Y. (1R,3S,5R,6S)-6-Hydr-oxy-3-tosyl-oxy-tropan-8-ium chloride.
Acta Crystallogr Sect E Struct Rep Online 2010;
66:o317. [PMID:
21579747 PMCID:
PMC2979886 DOI:
10.1107/s1600536809055366]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2009] [Accepted: 12/24/2009] [Indexed: 11/10/2022]
Abstract
The title compound, C15H22NO4S+·Cl−, is a hydrolysis product of lesatropane [(1R,3S,5R,6S)-6-acetoxy-3-tosyloxytropane] hydrochloride, a potential antiglaucoma agent. As in lesatropane, the piperidine and pyrrolidine rings in the title compound adopt chair and envelope conformations, respectively. There are two molecules in the unit cell with similar conformations. The crystal structure is stabilized by intermolecular O—H⋯Cl and N—H⋯Cl hydrogen bonds.
Collapse